Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Glaukos Corp GKOS

Healthcare Medical Devices
Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. The Company is focused on developing and commercializing therapies for the treatment of glaucoma, corneal disorders and retinal diseases. Its commercial solutions and development-stage product candidates include Micro-Invasive Glaucoma Surgery (MIGS) products that primarily involve the insertion of a micro-scale... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:GKOS)

RadiusXR and Glaukos Corporation Announce a New Collaboration With Topcon Healthcare, Inc. and the Launch of Inspire®: A Next-Generation Visual Field Solution

Business Wire 13 days ago

Glaukos Announces FDA Acceptance of NDA Submission for Epioxa(TM)

Business Wire February 24, 2025

Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results

Business Wire February 20, 2025

Glaukos to Release Fourth Quarter and Full Year 2024 Financial Results after Market Close on February 20

Business Wire January 23, 2025

Glaukos Announces Positive Clinical Updates for its iDose® Sustained-Release Procedural Pharmaceutical Platform

Business Wire January 14, 2025

Glaukos Submits New Drug Application to U.S. FDA for Epioxa(TM)

Business Wire December 23, 2024

Glaukos Announces Participation in the J.P. Morgan Healthcare Conference

Business Wire December 17, 2024

Glaukos Announces Participation in Upcoming Investor Conferences

Business Wire November 8, 2024

Glaukos Announces Third Quarter 2024 Financial Results

Business Wire November 4, 2024
View More News ››

Opinion & Analysis (NYSE:GKOS)

Avedro Shares Looking Up 35% with Glaukos Merger

Streetwise Reports August 13, 2019

Cutting-edge devices and diagnostics deliver drugs and profits: Cantor Fitzgerald's Caroline Corner

George S. Mack July 31, 2015
View More Opinion ››

Bullboard Posts (NYSE:GKOS)

GKOS Price Target Alert: $125.00. Issued by Jefferies

Breaking News: $GKOS GKOS Price Target Alert: $125.00. Issued by Jefferies2024-05-06 04:00:04 ET Michael Sarcone from Jefferies issued a...
whytestocks - May 6, 2024
View more Bullboard ››

Vista Gold Corp.

Vista Gold Corp.

Vista Gold Corp. (NYSE American and TSX: VGZ) holds the Mt Todd gold project, a shovel-ready development-stage deposit ...
View More »